Anti-citrullinated chemokine antibodies in pathofisiology, diagnostics and prognosis of rheumatoid arthritis
2016/23/B/NZ5/02627
Keywords
Descriptors
- NZ5_1: Etiologia chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Rzeszowski, Kolegium Nauk Medycznych
Voivodeship: podkarpackie
Principal investigator (from the host institution)
Number of co-investigators in the project: 4
Call
OPUS 12 – announced on 2016-09-15
- Amount awarded
- 1 058 600 PLN
- Project start date
- 2017-07-14
- Project end date
- 2022-07-13
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Mammalian glycosylation patterns protect citrullinated chem-okine MCP-1/CCL2 from partial degradation
- Authors:
- Olexandr Korchynskyi, Ken Yoshida, Justyna Czarnik-Kwaśniak, Paul-Peter Tak, Ger J.M.Pruijn, Takeo Isozaki , Jeffrey H. Ruth, Phillip L. Campbell, M.Asif Amin, and Alisa E. Koch
- Academic press:
- International Journal of Molecular Science (year: 2023, volume: 24, pages: 1862), Publisher: MDPI
- Status:
- Published
Book publications / chapters in book publications (1)
-
Special Issue
- Authors:
- Olexandr Korchynskyi, Ken Yoshida, Justyna Czarnik-Kwaśniak, Paul-Peter Tak, Ger J.M.Pruijn, Takeo Isozaki , Jeffrey H. Ruth, Phillip L. Campbell, M.Asif Amin, Alisa E. Koch
- Book:
- Research of Pathogenesis and Novel Therapeutics in Arthritis 3.0 (year: 2023, volume: 24, pages: 46158), Publisher: IJMS, MDPI
- Status:
- Published